An overview on 5α-reductase inhibitors (original) (raw)
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
Claus Roehrborn
Urology, 2002
View PDFchevron_right
Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Glenn Cunningham
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
Helmut Klocker
World Journal of Urology, 2002
View PDFchevron_right
Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia
Mario Reis
European Urology, 2004
View PDFchevron_right
Pharmacotherapy of benign prostatic hyperplasia: Inhibitor of 5 alpha-reductase
Azam Demirel
International Urology and Nephrology, 1997
View PDFchevron_right
Dihydrotestosterone and the concept of 5a-reductase inhibition in human benign prostatic hyperplasia
Helmut Klocker
World J Urol, 2002
View PDFchevron_right
The use of 5-alpha-reductase inhibitors for the prevention of prostate cancer
Walid El-Ayass
Cancer Biology & Therapy, 2010
View PDFchevron_right
Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
Samuel Silvestre
The Journal of Steroid Biochemistry and Molecular Biology, 2013
View PDFchevron_right
Steroid 5α-Reductase Inhibitors
Marisa Cabeza
Mini-Reviews in Medicinal Chemistry, 2003
View PDFchevron_right
Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5α-reductase inhibitor
Michael O'Leary
BJU International, 2003
View PDFchevron_right
Selective non-steroidal inhibitors of 5α-reductase type 1
giovanna danza
Journal of Steroid Biochemistry and Molecular Biology, 2004
View PDFchevron_right
Update on the use of dutasteride in the management of benign prostatic hypertrophy
Joe Miller
Clinical Interventions in Aging, 2007
View PDFchevron_right
Effects of 5α-reductase inhibitors on intraprostatic androgens in the rat
Achille Panzeri
Journal of Steroid Biochemistry and Molecular Biology, 1995
View PDFchevron_right
Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
Antonio Celia
Archivio Italiano di Urologia e Andrologia
View PDFchevron_right
Steroid 5α-Reductase Inhibitors
Alicia Quiroz
Mini-reviews in Medicinal Chemistry, 2003
View PDFchevron_right
Hormonal effects of turosteride, a 5α-reductase inhibitor, in the rat
Achille Panzeri
Journal of Steroid Biochemistry and Molecular Biology, 1993
View PDFchevron_right
Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor
Rosa Martinez
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001
View PDFchevron_right
Clinical application of 5α-reductase inhibitors
G. Danza
Journal of Endocrinological Investigation, 2001
View PDFchevron_right
The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study
P.eter Pommerville
The Prostate, 2006
View PDFchevron_right
The Effect of 5α-reductase Inhibition with Finasteride and Dutasteride on Bone Mineral Density in Older Men with Benign Prostatic Hyperplasia
Dora Cupic
Collegium Antropologicum, 2014
View PDFchevron_right
Role of 5 alpha-reductase inhibitors in the management of prostate cancer
Javier Hernandez
Clinical Interventions in Aging, 2006
View PDFchevron_right
Comparative study of human steroid 5α-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride
Russell Newton
Life Sciences, 2002
View PDFchevron_right
FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
Achille Panzeri
Journal of Steroid Biochemistry and Molecular Biology, 1996
View PDFchevron_right
Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5α-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia
Kiwon Chung
Endocrinology, 2004
View PDFchevron_right
Comparison of Clinical Trials With Finasteride and Dutasteride
Lenoo Benoo
View PDFchevron_right
Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor
Margarita Garcia
Journal of The American Chemical Society, 1996
View PDFchevron_right
5?-REDUCTASE Inhibition for Men with Enlarged Prostate
Muta Issa
Journal of the American Academy of Nurse Practitioners, 2007
View PDFchevron_right
Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073)
Achille Panzeri
Journal of Steroid Biochemistry and Molecular Biology, 1994
View PDFchevron_right
New 5α-reductase inhibitors: In vitro and in vivo effects
Elena Ramirez
Steroids, 2005
View PDFchevron_right